pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS ≥1, hrHPV+ Oropharyngeal Cancer
Conditions: Metastatic Oropharyngeal Carcinoma; Recurrent Oropharyngeal Carcinoma Interventions: Biological: DNA Vaccine; Biological: Human Papillomavirus Tumor Antigen Vaccine; Biological: Pembrolizumab; Procedure: Computed Tomography (CT); Procedure: Magnetic Resonance Imaging (MRI); Procedure: Magnetic Resonance Imaging; Procedure: Biopsy Sponsor: Michael K. Gibson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials
Elimisha HPV (Human Papillomavirus)
Conditions: Cervical Cancer; HPV; HIV; Stigma Intervention: Behavioral: Elimisha HPV Sponsors: Duke University; Fogarty International Center of the National Institute of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials